nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients
|
Scartozzi, M. |
|
|
22 |
4 |
p. 897-902 |
artikel |
2 |
Anti-CTLA-4 antibody-induced Guillain–Barré syndrome in a melanoma patient
|
Wilgenhof, S. |
|
|
22 |
4 |
p. 991-993 |
artikel |
3 |
Baseline nutritional evaluation in metastatic lung cancer patients: Mini Nutritional Assessment versus weight loss history
|
Gioulbasanis, I. |
|
|
22 |
4 |
p. 835-841 |
artikel |
4 |
Boning up on prognostic factors in advanced renal cell carcinoma
|
Tagawa, S.T. |
|
|
22 |
4 |
p. 751-753 |
artikel |
5 |
Breast cancer screening case–control study design: impact on breast cancer mortality
|
Paap, E. |
|
|
22 |
4 |
p. 863-869 |
artikel |
6 |
Chemotherapy in elderly small-cell lung cancer patients: yes we can, but should we do it?
|
Janssen-Heijnen, M.L.G. |
|
|
22 |
4 |
p. 821-826 |
artikel |
7 |
Clinical and genetic characterization of classical forms of familial adenomatous polyposis: a Spanish population study
|
Rivera, B. |
|
|
22 |
4 |
p. 903-909 |
artikel |
8 |
Correction to: Innovative technology for cancer risk analysis
|
|
|
|
22 |
4 |
p. 994 |
artikel |
9 |
Dietary supplement use patterns in men with prostate cancer: the Cancer Prostate Sweden Study
|
Westerlund, A. |
|
|
22 |
4 |
p. 967-972 |
artikel |
10 |
Double heterozygosity in the BRCA1 and BRCA2 genes in the Jewish population
|
Lavie, O. |
|
|
22 |
4 |
p. 964-966 |
artikel |
11 |
Editorial Board
|
|
|
|
22 |
4 |
p. ii-iii |
artikel |
12 |
Empowering induction therapy for locally advanced head and neck cancer
|
Argiris, A. |
|
|
22 |
4 |
p. 773-781 |
artikel |
13 |
End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin’s lymphoma
|
Barnes, J.A. |
|
|
22 |
4 |
p. 910-915 |
artikel |
14 |
European cancer mortality predictions for the year 2011
|
Malvezzi, M. |
|
|
22 |
4 |
p. 947-956 |
artikel |
15 |
Evaluation of psychosocial distress in patients treated in a community-based oncology group practice in Germany
|
Mergenthaler, U. |
|
|
22 |
4 |
p. 931-938 |
artikel |
16 |
Evolution in management of testicular seminoma: population-based outcomes with selective utilization of active therapies
|
Kollmannsberger, C. |
|
|
22 |
4 |
p. 808-814 |
artikel |
17 |
Expression of MAGE-A antigens is frequent in triple-negative breast cancers but does not correlate with that of basal-like markers
|
Hamaï, A. |
|
|
22 |
4 |
p. 986-987 |
artikel |
18 |
First evidence of oncologic neuropathic pain prevalence after screening 8615 cancer patients. Results of the On study
|
García de Paredes, M.L. |
|
|
22 |
4 |
p. 924-930 |
artikel |
19 |
Fulvestrant for advanced male breast cancer patients: a case series
|
Masci, G. |
|
|
22 |
4 |
p. 985 |
artikel |
20 |
Gastric atrophy and risk of oesophageal cancer and gastric cardia adenocarcinoma—a systematic review and meta-analysis
|
Islami, F. |
|
|
22 |
4 |
p. 754-760 |
artikel |
21 |
Impact of expression differences of kallikrein-related peptidases and of uPA and PAI-1 between primary tumor and omentum metastasis in advanced ovarian cancer
|
Dorn, J. |
|
|
22 |
4 |
p. 877-883 |
artikel |
22 |
Incidence of thyroid cancer in Italy, 1991–2005: time trends and age–period–cohort effects
|
Dal Maso, L. |
|
|
22 |
4 |
p. 957-963 |
artikel |
23 |
Increased haematopoietic progenitor cells are associated with poor outcome in patients with metastatic renal cancer treated with sunitinib
|
Powles, T. |
|
|
22 |
4 |
p. 815-820 |
artikel |
24 |
Indicators of homologous recombination deficiency in breast cancer and association with response to neoadjuvant chemotherapy
|
Lips, E.H. |
|
|
22 |
4 |
p. 870-876 |
artikel |
25 |
Long-term effects of anastrozole on bone mineral density: 7-year results from the ATAC trial
|
Eastell, R. |
|
|
22 |
4 |
p. 857-862 |
artikel |
26 |
Metabolic syndrome and endometrial cancer risk
|
Rosato, V. |
|
|
22 |
4 |
p. 884-889 |
artikel |
27 |
Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinib
|
Beuselinck, B. |
|
|
22 |
4 |
p. 794-800 |
artikel |
28 |
Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG)
|
Kosmidis, P.A. |
|
|
22 |
4 |
p. 827-834 |
artikel |
29 |
Pain management in spinal metastases: the role of percutaneous vertebral augmentation
|
Kassamali, R.H. |
|
|
22 |
4 |
p. 782-786 |
artikel |
30 |
Phase II study of a triplet regimen of S-1 combined with irinotecan and oxaliplatin in patients with metastatic gastric cancer: clinical and pharmacogenetic results
|
Park, S.R. |
|
|
22 |
4 |
p. 890-896 |
artikel |
31 |
Phase 3 study of docosahexaenoic acid–paclitaxel versus dacarbazine in patients with metastatic malignant melanoma
|
Bedikian, A.Y. |
|
|
22 |
4 |
p. 787-793 |
artikel |
32 |
Platinum-based chemotherapy in metastatic triple-negative breast cancer: the Institut Curie experience
|
Staudacher, L. |
|
|
22 |
4 |
p. 848-856 |
artikel |
33 |
Presence of the metabolic syndrome is associated with shorter time to castration-resistant prostate cancer
|
Flanagan, J. |
|
|
22 |
4 |
p. 801-807 |
artikel |
34 |
Quality of life during the course of cancer treatment in older newly diagnosed patients. Results of a prospective pilot study
|
Puts, M.T.E. |
|
|
22 |
4 |
p. 916-923 |
artikel |
35 |
Radiographic regression of cranial meningioma in a NF2 patient treated by bevacizumab
|
Goutagny, S. |
|
|
22 |
4 |
p. 990-991 |
artikel |
36 |
Risk factors for relapse after conservative treatment in T1–T2 breast cancer with one to three positive axillary nodes: results of an observational study
|
Aristei, C. |
|
|
22 |
4 |
p. 842-847 |
artikel |
37 |
Salvage radiotherapy in patients with recurrent or refractory primary or secondary central nervous system lymphoma after methotrexate-based chemotherapy
|
Khimani, N.B. |
|
|
22 |
4 |
p. 979-984 |
artikel |
38 |
Sorafenib may induce hypophosphatemia through a fibroblast growth factor-23 (FGF23)-independent mechanism
|
Bellini, E. |
|
|
22 |
4 |
p. 988-990 |
artikel |
39 |
Table of Contents
|
|
|
|
22 |
4 |
p. iv-vi |
artikel |
40 |
The relation between information provision and health-related quality of life, anxiety and depression among cancer survivors: a systematic review
|
Husson, O. |
|
|
22 |
4 |
p. 761-772 |
artikel |
41 |
Three palonosetron regimens to prevent CINV in myeloma patients receiving multiple-day high-dose melphalan and hematopoietic stem cell transplantation
|
Giralt, S.A. |
|
|
22 |
4 |
p. 939-946 |
artikel |
42 |
Trabectedin in the treatment of metastatic soft-tissue sarcoma: cost-effectiveness and cost–utility are yet to be proved
|
Blomqvist, C. |
|
|
22 |
4 |
p. 988 |
artikel |
43 |
Two doses of NGR-hTNF in combination with capecitabine plus oxaliplatin in colorectal cancer patients failing standard therapies
|
Mammoliti, S. |
|
|
22 |
4 |
p. 973-978 |
artikel |
44 |
Unity is strength: one, two, or more drugs against advanced pancreatic cancer?
|
Reni, M. |
|
|
22 |
4 |
p. 987 |
artikel |